104
Participants
Start Date
March 1, 2023
Primary Completion Date
June 30, 2023
Study Completion Date
June 30, 2023
IV Artesunate
IV artesunate with a weight-appropriate dosage at 0, 12, 24, and 48 hours and continued 12-hourly for a maximum duration of seven days, with each dose diluted in normal saline and given as an infusion.
IV Quinine Hydrochloride
IV Quinine hydrochloride in accordance to weight with loading dose 20mg salt/kg in 10% dextrose infusion followed by 10mg salt/kg infusion 8 hourly for 2 days and for 12 hourly onwards for a maximum of 7 days.
Allama Iqbal Teaching Hospital, Dera Ghazi Khan
RESnTEC, Institute of Research
OTHER